celecoxib has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
Excerpt | Relevance | Reference |
---|---|---|
"Celecoxib treatment also induced increases in utrophin A expression ranging from ∼1." | 1.48 | Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. ( Adam, NJ; Jasmin, BJ; Péladeau, C, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Péladeau, C | 1 |
Adam, NJ | 1 |
Jasmin, BJ | 1 |
1 other study available for celecoxib and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Diaphragm; Dystrophin; Mice; Mice, Inbred C57BL; Mice, Inbred | 2018 |